139 related articles for article (PubMed ID: 21546157)
21. Yeast cytosine deaminase mutants with increased thermostability impart sensitivity to 5-fluorocytosine.
Stolworthy TS; Korkegian AM; Willmon CL; Ardiani A; Cundiff J; Stoddard BL; Black ME
J Mol Biol; 2008 Mar; 377(3):854-69. PubMed ID: 18291415
[TBL] [Abstract][Full Text] [Related]
22. Multimodal image-guided enzyme/prodrug cancer therapy.
Li C; Winnard PT; Takagi T; Artemov D; Bhujwalla ZM
J Am Chem Soc; 2006 Nov; 128(47):15072-3. PubMed ID: 17117842
[TBL] [Abstract][Full Text] [Related]
23. Treatment of human tumor cells by combine gene therapy harnessing plasmids expressing human tumor necrosis factor alpha and bacterial cytosine deaminase suicide gene.
Pastorakova A; Hlubinova K; Altaner C
Neoplasma; 2006; 53(6):478-84. PubMed ID: 17167715
[TBL] [Abstract][Full Text] [Related]
24. Mutation of Escherichia coli cytosine deaminase significantly enhances molecular chemotherapy of human glioma.
Kaliberov SA; Market JM; Gillespie GY; Krendelchtchikova V; Della Manna D; Sellers JC; Kaliberova LN; Black ME; Buchsbaum DJ
Gene Ther; 2007 Jul; 14(14):1111-9. PubMed ID: 17495948
[TBL] [Abstract][Full Text] [Related]
25. A preliminary study on the construction of double suicide gene delivery vectors by mesenchymal stem cells and the in vitro inhibitory effects on SKOV3 cells.
Jiang J; Wei D; Sun L; Wang Y; Wu X; Li Y; Fang Z; Shang H; Wei Z
Oncol Rep; 2014 Feb; 31(2):781-7. PubMed ID: 24317390
[TBL] [Abstract][Full Text] [Related]
26. Strong enhancement of recombinant cytosine deaminase activity in Bifidobacterium longum for tumor-targeting enzyme/prodrug therapy.
Hamaji Y; Fujimori M; Sasaki T; Matsuhashi H; Matsui-Seki K; Shimatani-Shibata Y; Kano Y; Amano J; Taniguchi S
Biosci Biotechnol Biochem; 2007 Apr; 71(4):874-83. PubMed ID: 17420581
[TBL] [Abstract][Full Text] [Related]
27. Magnetic nanoparticle hyperthermia induced cytosine deaminase expression in microencapsulated E. coli for enzyme-prodrug therapy.
Nemani KV; Ennis RC; Griswold KE; Gimi B
J Biotechnol; 2015 Jun; 203():32-40. PubMed ID: 25820125
[TBL] [Abstract][Full Text] [Related]
28. The oncolytic effect of recombinant vesicular stomatitis virus is enhanced by expression of the fusion cytosine deaminase/uracil phosphoribosyltransferase suicide gene.
Porosnicu M; Mian A; Barber GN
Cancer Res; 2003 Dec; 63(23):8366-76. PubMed ID: 14678998
[TBL] [Abstract][Full Text] [Related]
29. Selective radiosensitization of 9L glioma in the brain transduced with double suicide fusion gene.
Kim JH; Kolozsvary A; Rogulski K; Khil MS; Brown SL; Freytag SO
Cancer J Sci Am; 1998; 4(6):364-9. PubMed ID: 9853135
[TBL] [Abstract][Full Text] [Related]
30. Human neural stem cells can target and deliver therapeutic genes to breast cancer brain metastases.
Joo KM; Park IH; Shin JY; Jin J; Kang BG; Kim MH; Lee SJ; Jo MY; Kim SU; Nam DH
Mol Ther; 2009 Mar; 17(3):570-5. PubMed ID: 19127251
[TBL] [Abstract][Full Text] [Related]
31. Multimodality therapy with a replication-conditional herpes simplex virus 1 mutant that expresses yeast cytosine deaminase for intratumoral conversion of 5-fluorocytosine to 5-fluorouracil.
Nakamura H; Mullen JT; Chandrasekhar S; Pawlik TM; Yoon SS; Tanabe KK
Cancer Res; 2001 Jul; 61(14):5447-52. PubMed ID: 11454690
[TBL] [Abstract][Full Text] [Related]
32. Cytotoxic effects of 5-fluorocytosine on melanoma cells transduced with cytosine deaminase gene.
Lü H; Wu D; Wan Y; Gu B; Wang J
J Environ Pathol Toxicol Oncol; 2000; 19(1-2):9-12. PubMed ID: 10905502
[TBL] [Abstract][Full Text] [Related]
33. Direct and bystander killing of sarcomas by novel cytosine deaminase fusion gene.
Ramnaraine M; Pan W; Goblirsch M; Lynch C; Lewis V; Orchard P; Mantyh P; Clohisy DR
Cancer Res; 2003 Oct; 63(20):6847-54. PubMed ID: 14583482
[TBL] [Abstract][Full Text] [Related]
34. Enzyme/prodrug-based tumor vaccination: all politics (and immunity) are local.
Morris JC
J Natl Cancer Inst; 1999 Dec; 91(23):1986-9. PubMed ID: 10580014
[No Abstract] [Full Text] [Related]
35. Nanoplex delivery of siRNA and prodrug enzyme for multimodality image-guided molecular pathway targeted cancer therapy.
Li C; Penet MF; Wildes F; Takagi T; Chen Z; Winnard PT; Artemov D; Bhujwalla ZM
ACS Nano; 2010 Nov; 4(11):6707-16. PubMed ID: 20958072
[TBL] [Abstract][Full Text] [Related]
36. Selective antitumor effect of neural stem cells expressing cytosine deaminase and interferon-beta against ductal breast cancer cells in cellular and xenograft models.
Yi BR; Hwang KA; Aboody KS; Jeung EB; Kim SU; Choi KC
Stem Cell Res; 2014 Jan; 12(1):36-48. PubMed ID: 24141111
[TBL] [Abstract][Full Text] [Related]
37. In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosine deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine.
Hirschowitz EA; Ohwada A; Pascal WR; Russi TJ; Crystal RG
Hum Gene Ther; 1995 Aug; 6(8):1055-63. PubMed ID: 7578418
[TBL] [Abstract][Full Text] [Related]
38. A novel oncolytic adenovirus expressing Escherichia coli cytosine deaminase exhibits potent antitumor effect on human solid tumors.
Zhang J; Wei F; Wang H; Li H; Qiu W; Ren P; Chen X; Huang Q
Cancer Biother Radiopharm; 2010 Aug; 25(4):487-95. PubMed ID: 20735209
[TBL] [Abstract][Full Text] [Related]
39. 5-Fluorocytosine combined with Fcy-hEGF fusion protein targets EGFR-expressing cancer cells.
Lan KH; Shih YS; Chang CA; Yen SH; Lan KL
Biochem Biophys Res Commun; 2012 Nov; 428(2):292-7. PubMed ID: 23085230
[TBL] [Abstract][Full Text] [Related]
40. Cytotoxic effect of replication-competent adenoviral vectors carrying L-plastin promoter regulated E1A and cytosine deaminase genes in cancers of the breast, ovary and colon.
Akbulut H; Zhang L; Tang Y; Deisseroth A
Cancer Gene Ther; 2003 May; 10(5):388-95. PubMed ID: 12719708
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
